Carisoprodol: Revizyonlar arasındaki fark

Diğerlerinin yanı sıra '''Soma''' markası altında satılan '''Carisoprodol''', [[İnsan kas-iskelet sistemi|kas-iskelet sistemi]] ağrılarında kullanılan bir ilaçtır.<ref name="AHFS2019">{{Web kaynağı|url=https://www.drugs.com/monograph/carisoprodol.html|başlık=Carisoprodol Monograph for Professionals|erişimtarihi=8 April 2019|arşivtarihi=18 June 2019|arşivurl=https://web.archive.org/web/20190618020542/https://www.drugs.com/monograph/carisoprodol.html|dil=en|çalışma=Drugs.com|yayıncı=American Society of Health-System Pharmacists}}</ref> Kullanım yalnızca üç haftaya kadar onaylanmıştır.<ref name="AHFS2019">{{cite web |title=Carisoprodol Monograph for Professionals |url=https://www.drugs.com/monograph/carisoprodol.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |accessdate=8 April 2019 |language=en |archive-date=18 June 2019 |archive-url=https://web.archive.org/web/20190618020542/https://www.drugs.com/monograph/carisoprodol.html |url-status=live }}</ref> Etkiler genellikle yarım saat içinde başlar ve altı saate kadar sürmektedir<ref name="AHFS2019">{{cite web |title=Carisoprodol Monograph for Professionals |url=https://www.drugs.com/monograph/carisoprodol.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |accessdate=8 April 2019 |language=en |archive-date=18 June 2019 |archive-url=https://web.archive.org/web/20190618020542/https://www.drugs.com/monograph/carisoprodol.html |url-status=live }}</ref> ve ilaç ağız yoluyla alınır.<ref name="AHFS2019">{{cite web |title=Carisoprodol Monograph for Professionals |url=https://www.drugs.com/monograph/carisoprodol.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |accessdate=8 April 2019 |language=en |archive-date=18 June 2019 |archive-url=https://web.archive.org/web/20190618020542/https://www.drugs.com/monograph/carisoprodol.html |url-status=live }}</ref>

Yaygın yan etkiler baş ağrısı, baş dönmesi ve uyku yapmasıdır.<ref name="AHFS2019">{{Web kaynağı|url=https://www.drugs.com/monograph/carisoprodol.html|başlık=Carisoprodol Monograph for Professionals|erişimtarihi=8 April 2019|arşivtarihi=18 June 2019|arşivurl=https://web.archive.org/web/20190618020542/https://www.drugs.com/monograph/carisoprodol.html|dil=en|çalışma=Drugs.com|yayıncı=American Society of Health-System Pharmacists}}<cite class="citation web cs1" data-ve-ignore="true">[https://www.drugs.com/monograph/carisoprodol.html "Carisoprodol Monograph for Professionals"]. </cite></ref> Ciddi yan etkiler arasında [[bağımlılık]], [[Alerji|alerjik reaksiyonlar]] ve [[Nöbet (tıp)|nöbetler]] yer alabilir.<ref name="AHFS2019">{{cite web |title=Carisoprodol Monograph for Professionals |url=https://www.drugs.com/monograph/carisoprodol.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |accessdate=8 April 2019 |language=en |archive-date=18 June 2019 |archive-url=https://web.archive.org/web/20190618020542/https://www.drugs.com/monograph/carisoprodol.html |url-status=live }}</ref> Sülfa alerjisi olan kişilerde belirli formülasyonlar sorunlara neden olabilir.<ref name="AHFS2019">{{cite web |title=Carisoprodol Monograph for Professionals |url=https://www.drugs.com/monograph/carisoprodol.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |accessdate=8 April 2019 |language=en |archive-date=18 June 2019 |archive-url=https://web.archive.org/web/20190618020542/https://www.drugs.com/monograph/carisoprodol.html |url-status=live }}</ref> [[Hamilelik]] ve [[emzirme]] döneminde güvenliği net değildir.<ref>{{Web kaynağı|url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab22f1be-16c8-45b6-adaf-09e08bf7a545|başlık=DailyMed - carisoprodol tablet|erişimtarihi=8 April 2019|arşivtarihi=24 November 2020|arşivurl=https://web.archive.org/web/20201124060233/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab22f1be-16c8-45b6-adaf-09e08bf7a545|çalışma=dailymed.nlm.nih.gov}}</ref><ref name="AHFS2019">{{cite web |title=Carisoprodol Monograph for Professionals |url=https://www.drugs.com/monograph/carisoprodol.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |accessdate=8 April 2019 |language=en |archive-date=18 June 2019 |archive-url=https://web.archive.org/web/20190618020542/https://www.drugs.com/monograph/carisoprodol.html |url-status=live }}</ref> Nasıl çalıştığı belli değildir<ref name="AHFS2019">{{cite web |title=Carisoprodol Monograph for Professionals |url=https://www.drugs.com/monograph/carisoprodol.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |accessdate=8 April 2019 |language=en |archive-date=18 June 2019 |archive-url=https://web.archive.org/web/20190618020542/https://www.drugs.com/monograph/carisoprodol.html |url-status=live }}</ref> ve bazı etkilerinin meprobamat'a dönüştürülmesinin ardından ortaya çıktığına inanılmaktadır. <ref name="AHFS2019">{{cite web |title=Carisoprodol Monograph for Professionals |url=https://www.drugs.com/monograph/carisoprodol.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |accessdate=8 April 2019 |language=en |archive-date=18 June 2019 |archive-url=https://web.archive.org/web/20190618020542/https://www.drugs.com/monograph/carisoprodol.html |url-status=live }}</ref>

Carisoprodol, 1959'da Amerika Birleşik Devletleri'nde tıbbi kullanım için onaylandıktan sonra<ref name="AHFS2019">{{Web kaynağı|url=https://www.drugs.com/monograph/carisoprodol.html|başlık=Carisoprodol Monograph for Professionals|erişimtarihi=8 April 2019|arşivtarihi=18 June 2019|arşivurl=https://web.archive.org/web/20190618020542/https://www.drugs.com/monograph/carisoprodol.html|dil=en|çalışma=Drugs.com|yayıncı=American Society of Health-System Pharmacists}}<cite class="citation web cs1" data-ve-ignore="true">[https://www.drugs.com/monograph/carisoprodol.html "Carisoprodol Monograph for Professionals"]. </cite></ref> Avrupa'da onayı 2008 yılında geri çekilmiştir.<ref>{{Web kaynağı|url=https://www.ema.europa.eu/en/medicines/human/referrals/carisoprodol|başlık=Carisoprodol|erişimtarihi=8 April 2019|arşivtarihi=8 April 2019|arşivurl=https://web.archive.org/web/20190408134933/https://www.ema.europa.eu/en/medicines/human/referrals/carisoprodol|tarih=15 November 2007|dil=en|çalışma=European Medicines Agency}}</ref> [[Jenerik ilaç|Jenerik bir ilaç]] olarak kullanılır.<ref name="AHFS2019">{{cite web |title=Carisoprodol Monograph for Professionals |url=https://www.drugs.com/monograph/carisoprodol.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |accessdate=8 April 2019 |language=en |archive-date=18 June 2019 |archive-url=https://web.archive.org/web/20190618020542/https://www.drugs.com/monograph/carisoprodol.html |url-status=live }}</ref> Amerika Birleşik Devletleri'nde toptan satış maliyeti doz başına 0,10 ABD Dolarından azdır.<ref name="ref">{{Web kaynağı|url=https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6|başlık=NADAC as of 2019-02-27 {{!}} Data.Medicaid.gov|erişimtarihi=8 April 2019|arşivtarihi=6 March 2019|arşivurl=https://web.archive.org/web/20190306044447/https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6|dil=en|çalışma=Centers for Medicare and Medicaid Services}}</ref> 2017 yılında, bir milyondan fazla reçeteyle Amerika Birleşik Devletleri'nde en sık reçete edilen 255. ilaç olan ilaç<ref name="ref1">{{Web kaynağı|url=https://clincalc.com/DrugStats/Top300Drugs.aspx|başlık=The Top 300 of 2020|erişimtarihi=11 April 2020|arşivtarihi=12 February 2021|arşivurl=https://web.archive.org/web/20210212142534/https://clincalc.com/DrugStats/Top300Drugs.aspx|çalışma=ClinCalc}}</ref><ref name="ref2">{{Web kaynağı|url=https://clincalc.com/DrugStats/Drugs/Carisoprodol|başlık=Carisoprodol - Drug Usage Statistics|erişimtarihi=11 April 2020|arşivtarihi=8 July 2020|arşivurl=https://web.archive.org/web/20200708065729/https://clincalc.com/DrugStats/Drugs/Carisoprodol|çalışma=ClinCalc}}</ref> Amerika Birleşik Devletleri'nde, Çizelge IV kontrollü bir maddedir. <ref name="AHFS2019">{{cite web |title=Carisoprodol Monograph for Professionals |url=https://www.drugs.com/monograph/carisoprodol.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |accessdate=8 April 2019 |language=en |archive-date=18 June 2019 |archive-url=https://web.archive.org/web/20190618020542/https://www.drugs.com/monograph/carisoprodol.html |url-status=live }}</ref>